EASL 2013: Daclatasvir plus Interfero...

EASL 2013: Daclatasvir plus Interferon Cures More Genotype 2/3 Hepatitis C Patients

There are 1 comment on the HIV and Hepatitis story from May 4, 2013, titled EASL 2013: Daclatasvir plus Interferon Cures More Genotype 2/3 Hepatitis C Patients. In it, HIV and Hepatitis reports that:

Adding the HCV NS5A inhibitor daclatasvir to pegylated interferon and ribavirin for 12 or 16 weeks led to higher response rates for previously untreated people with genotype 2 or 3 hepatitis C, according to results from the COMMAND study reported last week at the EASL International Liver Congress in Amsterdam.

Join the discussion below, or Read more at HIV and Hepatitis.



#1 May 4, 2013
This disease is now cured in most people with this treatment, what a great job by the medical researchers

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Health Discussions

Title Updated Last By Comments
Morgellons - What I believe it really is (Oct '12) 8 hr real 372
News Poll: 70 percent of Kentuckians support $1 toba... 12 hr Say What 40
News Pregnancy Symptoms - 12 Very Early Symptoms of ... (Jun '07) 14 hr Yougogirl 7,319
News Major shift as Trump opens way for Medicaid wor... 16 hr spocko 113
Esophagus Spasm - How my mom STOPS her Esophage... (May '12) Tue Beth 297
News Millions more Americans were uninsured in 2017 Tue notfromhere 1
News Ohio approves state smoking ban (Nov '06) Tue TruthBeTold 76,023
watching wife get pregnant by another man (Jan '17) Jan 14 willthis23 35
More from around the web